Danaher Corporation $DHR Stock: Sigma Investment Counselors Inc. Boosts Position

Sigma Investment Counselors Inc. lifted its stake in Danaher Corporation (NYSE:DHR) by 11.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,589 shares of the conglomerate’s stock after acquiring an additional 2,642 shares during the period. Sigma Investment Counselors Inc.’s holdings in Danaher were worth $5,669,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Prime Capital Investment Advisors LLC boosted its stake in Danaher by 0.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock worth $2,039,000 after purchasing an additional 45 shares during the period. Veery Capital LLC increased its position in shares of Danaher by 3.1% during the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after buying an additional 48 shares during the period. Studio Investment Management LLC increased its position in shares of Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after buying an additional 51 shares during the period. Meridian Financial Partners LLC lifted its holdings in shares of Danaher by 1.2% in the third quarter. Meridian Financial Partners LLC now owns 4,636 shares of the conglomerate’s stock worth $1,073,000 after buying an additional 56 shares in the last quarter. Finally, Adelphi Trust Co lifted its holdings in shares of Danaher by 2.5% in the third quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock worth $524,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Performance

NYSE DHR opened at $232.00 on Wednesday. The company has a 50-day simple moving average of $217.41 and a two-hundred day simple moving average of $201.82. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $1.92 by $0.19. The company had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. During the same quarter in the prior year, the firm posted $1.89 EPS. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. Sell-side analysts expect that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. TD Cowen raised their price target on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Barclays boosted their price target on shares of Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Evercore restated an “outperform” rating and set a $230.00 price target on shares of Danaher in a research report on Monday, July 6th. Finally, Citigroup upped their price target on shares of Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.